The way the SEC and OTC Markets have handled this fundamental change to the OTC market is ridiculous. Before these two entities set deadlines for implementation, all of the details/minutia of this change is something that should have been worked out and settled on a long time ago. I find it mind-boggling this far into the process that neither OTC Markets nor the SEC apparently have a definitive answer to the question below.....
Does the SEC's new 18-month time frame for shells start after the September 28 deadline, or is that 18-month time frame applied retroactively?
Based on guidance/statements that OTC Markets has made regarding this issue, investors/custodians/companies have been working under the belief that any shell that is current in its filing/profile obligations will be allowed quotations for 18 months after the September deadline. This guidance apparently is based on OTC Markets understanding of the rule and its conversations with the SEC. However, apparently OTC Markets still doesn't actually have confirmation yet from the SEC that its guidance is actually going to be accurate.
This Securities Lawyer 101 blog below (scroll down to the section on shell companies) makes a pretty good point of this. It is entirely possible that the SEC intended this amendment to be applied retroactively. Shells could be completely current/updated in all their reporting obligations to OTC Markets, but it wouldn't make any difference. They would immediately lose their quotations after the September deadline because they have already been shells for 18 months.
Normally I might be willing to place my trust that OTC Markets guidance based on its "conversations" with the SEC might turn out to be accurate. But given how OTC Markets' "conversations" with the SEC regarding the whole Expert Market thing didn't exactly turn out well, I think there are some legitimate reasons to have some concerns here.......
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.